Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.29 is 22% below its 5-year average of 2.95, around the middle of its 5-year range (1.24–4.39).
As of the fiscal period ended Tuesday, June 30, 2026. 27.60% below its 12-month average of 3.17.
Reported quarterly current ratio; no daily interpolation.
CURRENT RATIO
2.29
CURRENT RATIO AVG TTM
3.17
CURRENT RATIO AVG 3Y
3.50
CURRENT RATIO AVG 5Y
2.95
CURRENT RATIO AVG 10Y
3.31
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-27.60%
CURRENT VS 3Y AVG
-34.48%
CURRENT VS 5Y AVG
-22.19%
CURRENT VS 10Y AVG
-30.77%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
1.54
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+49.01%
vs the sector median at left
Market Cap
$49.91B
Current Ratio
4.52
TTM Avg
3.95
3Y Avg
3.58
5Y Avg
3.47
Market Cap
$49.78B
Current Ratio
0.87
TTM Avg
1.14
3Y Avg
1.16
5Y Avg
1.25
Market Cap
$43.07B
Current Ratio
0.88
TTM Avg
1.01
3Y Avg
1.02
5Y Avg
1.04
Market Cap
$68.12B
Current Ratio
1.24
TTM Avg
1.35
3Y Avg
1.38
5Y Avg
1.47
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Moderna, Inc. (MRNA) | $54.89B | 2.29 | 3.17 | 3.50 | 2.95 |
| Cardinal Health, Inc. (CAH)vs › | $56.31B | 0.88 | 0.91 | 0.95 | 1.00 |
| Edwards Lifesciences Corporation (EW)vs › | $49.91B | 4.52 | 3.95 | 3.58 | 3.47 |
| Becton, Dickinson and Company (BDX)vs › | $49.78B | 0.87 | 1.14 | 1.16 | 1.25 |
| Humana Inc. (HUM)vs › | $47.18B | 1.74 | 0.58 | 0.57 | 0.58 |
| Cencora, Inc. (COR)vs › | $63.37B | 0.93 | 0.89 | 0.89 | 0.92 |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $43.07B | 0.88 | 1.01 | 1.02 | 1.04 |
| IQVIA Holdings Inc. (IQV)vs › | $42.12B | 0.71 | 0.79 | 0.83 | 0.90 |
| Boston Scientific Corporation (BSX)vs › | $68.12B | 1.24 | 1.35 | 1.38 | 1.47 |
| IDEXX Laboratories, Inc. (IDXX)vs › | $40.97B | 1.17 | 1.24 | 1.23 | 1.33 |
Current Ratio
2.29
Quick Ratio
2.18
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.29 |
| 2026-03-31 | 2.41 |
| 2025-12-31 | 3.29 |
| 2025-09-30 | 3.93 |
| 2025-06-30 | 3.93 |
| 2025-03-31 | 4.22 |
| 2024-12-31 | 3.67 |
| 2024-09-30 | 4.39 |
| 2024-06-30 | 4.09 |
| 2024-03-31 | 4.03 |
| 2023-12-31 | 3.42 |
| 2023-09-30 | 2.46 |
| 2023-06-30 | 3.39 |
| 2023-03-31 | 3.46 |
| 2022-12-31 | 2.73 |
| 2022-09-30 | 2.10 |
| 2022-06-30 | 1.99 |
| 2022-03-31 | 1.77 |
| 2021-12-31 | 1.76 |
| 2021-09-30 | 1.35 |
| 2021-06-30 | 1.24 |
| 2021-03-31 | 1.39 |
| 2020-12-31 | 1.43 |
| 2020-09-30 | 2.43 |
| 2020-06-30 | 17.30 |
| 2020-03-31 | 9.29 |
| 2019-12-31 | 7.89 |
| 2019-09-30 | 7.40 |
| 2019-06-30 | 6.77 |
| 2019-03-31 | 7.17 |
| 2018-12-31 | 7.02 |
| 2018-09-30 | 6.00 |
| 2018-06-30 | 5.81 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 4.09 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
